» Articles » PMID: 14769646

Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2004 Feb 11
PMID 14769646
Citations 382
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to determine skeletal muscle cutpoints for identifying elevated physical disability risk in older adults. Subjects included 4,449 older (> or = 60 years) participants from the Third National Health and Nutrition Examination Survey during 1988-1994. Physical disability was assessed by questionnaire, and bioimpedance was used to estimate skeletal muscle, which was normalized for height. Receiver operating characteristics were used to develop the skeletal muscle cutpoints associated with a high likelihood of physical disability. Odds for physical disability were compared in subjects whose measures fell above and below these cutpoints. Skeletal muscle cutpoints of 5.76-6.75 and < or =5.75 kg/m2 were selected to denote moderate and high physical disability risk in women. The corresponding values in men were 8.51-10.75 and < or =8.50 kg/m2. Compared with women with low-risk skeletal muscle values, women with moderate- and high-risk skeletal muscle values had odds for physical disability of 1.41 (95% confidence interval (CI): 0.97, 2.04) and 3.31 (95% CI: 1.91, 5.73), respectively. The corresponding odds in men were 3.65 (95% CI: 1.92, 6.94) and 4.71 (95% CI: 2.28, 9.74). This study presents skeletal muscle cutpoints for physical disability risk in older adults. Future applications of these cutpoints include the comparison of morbidity risk in older persons with normal muscle mass and those with sarcopenia, the determination and comparison of sarcopenia prevalences, and the estimation of health-care costs attributable to sarcopenia.

Citing Articles

The correlation between serum alkaline phosphatase and grip strength in middle-aged and elderly people: NHANES 2011-2014.

Zhang Z, Zhou J, Ma A, Chen H, Wang B, Zhao G BMC Musculoskelet Disord. 2025; 26(1):191.

PMID: 40000994 PMC: 11853681. DOI: 10.1186/s12891-025-08408-2.


Effect of Reablement Strategies targeting Sarcopenia (ReStart-S) on sarcopenic older adults residing in long term care settings: A protocol for cluster randomized trial.

Kumar P, Umakanth S, Bruyere O, N G Heliyon. 2025; 11(3):e42174.

PMID: 39944329 PMC: 11815644. DOI: 10.1016/j.heliyon.2025.e42174.


Impact of physical activity on physical function, mitochondrial energetics, ROS production, and Ca handling across the adult lifespan in men.

Cefis M, Marcangeli V, Hammad R, Granet J, Leduc-Gaudet J, Gaudreau P Cell Rep Med. 2025; 6(2):101968.

PMID: 39933528 PMC: 11866497. DOI: 10.1016/j.xcrm.2025.101968.


Systematic Review of Sarcopenia Biomarkers in Hip Fracture Patients as a Potential Tool in Clinical Evaluation.

Brzeszczynski F, Hamilton D, Bonczak O, Brzeszczynska J Int J Mol Sci. 2025; 25(24.

PMID: 39769198 PMC: 11679566. DOI: 10.3390/ijms252413433.


Correlation and predictive value of novel anthropometric indicators with adult sarcopenia and sarcopenia obesity.

Wu X, Chen Z, Zhao Y, Ren H Sci Rep. 2024; 14(1):31776.

PMID: 39738342 PMC: 11685711. DOI: 10.1038/s41598-024-82751-7.